1. Home
  2. CAN vs BMEA Comparison

CAN vs BMEA Comparison

Compare CAN & BMEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CAN
  • BMEA
  • Stock Information
  • Founded
  • CAN 2013
  • BMEA 2017
  • Country
  • CAN Singapore
  • BMEA United States
  • Employees
  • CAN N/A
  • BMEA N/A
  • Industry
  • CAN Semiconductors
  • BMEA Biotechnology: Pharmaceutical Preparations
  • Sector
  • CAN Technology
  • BMEA Health Care
  • Exchange
  • CAN Nasdaq
  • BMEA Nasdaq
  • Market Cap
  • CAN 359.7M
  • BMEA 275.6M
  • IPO Year
  • CAN 2019
  • BMEA 2021
  • Fundamental
  • Price
  • CAN $1.26
  • BMEA $8.18
  • Analyst Decision
  • CAN Strong Buy
  • BMEA Buy
  • Analyst Count
  • CAN 4
  • BMEA 13
  • Target Price
  • CAN $3.38
  • BMEA $37.25
  • AVG Volume (30 Days)
  • CAN 7.8M
  • BMEA 805.0K
  • Earning Date
  • CAN 11-26-2024
  • BMEA 10-29-2024
  • Dividend Yield
  • CAN N/A
  • BMEA N/A
  • EPS Growth
  • CAN N/A
  • BMEA N/A
  • EPS
  • CAN N/A
  • BMEA N/A
  • Revenue
  • CAN $189,341,000.00
  • BMEA N/A
  • Revenue This Year
  • CAN $23.62
  • BMEA N/A
  • Revenue Next Year
  • CAN $58.80
  • BMEA N/A
  • P/E Ratio
  • CAN N/A
  • BMEA N/A
  • Revenue Growth
  • CAN N/A
  • BMEA N/A
  • 52 Week Low
  • CAN $0.72
  • BMEA $3.61
  • 52 Week High
  • CAN $3.50
  • BMEA $22.74
  • Technical
  • Relative Strength Index (RSI)
  • CAN 55.22
  • BMEA 32.99
  • Support Level
  • CAN $1.14
  • BMEA $8.60
  • Resistance Level
  • CAN $1.49
  • BMEA $9.34
  • Average True Range (ATR)
  • CAN 0.13
  • BMEA 0.81
  • MACD
  • CAN 0.03
  • BMEA -0.45
  • Stochastic Oscillator
  • CAN 56.60
  • BMEA 3.11

About CAN Canaan Inc.

Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment as well as the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts.

About BMEA Biomea Fusion Inc.

Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.

Share on Social Networks: